Document is current
Any future updates will be listed below
-
Authors
Zhang, Jing
Gutierrez-Lara, Erika Joana
Do, Aryanne
Nguyen, Lena
Nair, Anju
Selvan, Nithya
Fenn, Tim
Adler, Eric
Khanna, Richie
Sheikh, Farah
-
Funding
Funding for this research was provided by:
National Institutes of Health (HL142251)
LEXEO Therapeutics Inc.
- License Information
-
More Information
Article History
Received: 5 November 2024
Accepted: 25 February 2025
First Online: 3 April 2025
Change Date: 24 April 2025
Change Type: Update
Change Details: In this article Sonia Gutierrez Granados and Ken Law were mistakenly acknowledged for overseeing drug manufacturing and analytical analysis in the Acknowledgements section. The original article has been corrected.
Competing interests
: F.S. was a co-founder of Stelios Therapeutics Inc. (acquired by LEXEO Therapeutics Inc.) and is a co-founder and shareholder of Papillon Therapeutics and MyoTherapeutix Inc as well as a consultant and shareholder of LEXEO Therapeutics Inc. F.S. serves as Associate Editor of this journal but had no role in the peer review process or decision to publish this manuscript.
